Galsome

Galsome is an innovative Israeli biotechnology company dedicated to advancing women's health through the development of next-generation vaginal drug delivery systems. The company has developed a proprietary smart vaginal ring platform designed to provide precise, controlled, and long-term release of various therapeutic agents. Galsome's primary focus is on improving hormone replacement therapy (HRT) for menopausal women, offering a more consistent delivery method compared to traditional options. Beyond HRT, the company is exploring applications for its platform in contraception and the treatment of vaginal infections, aiming to improve patient compliance and clinical outcomes in gynecological care.